Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quarg

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Alzheimer Disease and Associated Disorders|October 21, 2004
Disease stage in Alzheimer disease and treatment effects of rivastigmineAlexander Kurz, Martin Farlow, Peter Quarg, et al.
Dementia and Geriatric Cognitive Disorders|August 10, 2005
Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysisMartin R Farlow, Gary W Small, Peter Quarg, et al.
Pharmaceutical Statistics|June 25, 2021
Identifying treatment effects using trimmed means when data are missing not at randomAlex Ocampo, Heinz Schmidli, Peter Quarg, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly SubjectsMarc Vandemeulebroecke, Björn Bornkamp, Tillmann Krahnke, et al.
The New England Journal of Medicine|December 14, 2004
Rivastigmine for dementia associated with Parkinson's diseaseMurat Emre, Dag Aarsland, Alberto Albanese, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Alzheimer Disease and Associated Disorders|October 21, 2004
Disease stage in Alzheimer disease and treatment effects of rivastigmineAlexander Kurz, Martin Farlow, Peter Quarg, et al.
Dementia and Geriatric Cognitive Disorders|August 10, 2005
Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysisMartin R Farlow, Gary W Small, Peter Quarg, et al.
Pharmaceutical Statistics|June 25, 2021
Identifying treatment effects using trimmed means when data are missing not at randomAlex Ocampo, Heinz Schmidli, Peter Quarg, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly SubjectsMarc Vandemeulebroecke, Björn Bornkamp, Tillmann Krahnke, et al.
The New England Journal of Medicine|December 14, 2004
Rivastigmine for dementia associated with Parkinson's diseaseMurat Emre, Dag Aarsland, Alberto Albanese, et al.
Pageof 1